As a decisive advocate for clinical trial diversity, Kate has been an invaluable partner to Biogen’s Public Policy and Government Affairs team. She has helped spotlight key initiatives like Biogen’s partnership with the Morehouse School of Medicine and the launch of a new national minority trial index.
Kate Wilson
